日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial

吉西他滨辅助治疗与新辅助/辅助 FOLFIRINOX 方案治疗可切除胰腺癌的疗效比较:随机多中心 II 期 NEPAFOX 试验

Goetze, Thorsten O; Reichart, Alexander; Bankstahl, Ulli S; Pauligk, Claudia; Loose, Maria; Kraus, Thomas W; Elshafei, Moustafa; Bechstein, Wolf O; Trojan, Jörg; Behrend, Matthias; Homann, Nils; Venerito, Marino; Bohle, Wolfram; Varvenne, Michael; Bolling, Claus; Behringer, Dirk M; Kratz-Albers, Karsten; Siegler, Gabriele M; Hozaeel, Wael; Al-Batran, Salah-Eddin

The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease

异基因造血干细胞移植后预防性输注供体淋巴细胞的移植物抗白血病效应,在预防复发方面同样有效,但与自发性移植物抗宿主病相比更安全。

Stadler, Michael; Hambach, Lothar; Dammann, Elke; Diedrich, Helmut; Kamal, Haytham; Hamwi, Iyas; Schultze-Florey, Christian; Varvenne, Michael; Ehrlich, Steve; Buchholz, Stefanie; Koenecke, Christian; Beutel, Gernot; Weissinger, Eva M; Krauter, Jürgen; Eder, Matthias; Hertenstein, Bernd; Ganser, Arnold